Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.

Vaccine - 31 Jan 2002

Gampfer Jörg, Thon Vojtech, Gulle Heinz, Wolf Hermann M, Eibl Martha M

Abstract excerpt

Up to now there is no treatment for staphylococcal toxic shock syndrome, a disease mainly induced by toxic shock syndrome toxin-1(TSST-1). There is great demand in finding means to control the disease, one of them is the development of an effective and safe vaccine against TSST-1. In this study we constructed a series of vaccine candidates and investigated their biological activity, toxicity, and potential to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Bacterial
Share to Enterotoxins
Share to Formaldehyde

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mitogens

Share to Shock, Septic

Share to Superantigens

Share to Vaccines, Inactivated

Share to Vaccines, Synthetic

Source

Identifiers

PMID: 11818153
DOI: 10.1016/s0264-410x(01)00470-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.PMID 11818153Read ↗

Staphylococcal Enterotoxin B and C Mutants and Vaccine ToxoidsSemantic proximity Read ↗

Identification of a novel fully human anti-toxic shock syndrome toxin (TSST)-1 single-chain variable fragment antibody averting TSST-1-induced mitogenesis and cytokine secretionSemantic proximity Read ↗

Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.Semantic proximity Read ↗

Staphylococcal superantigen (TSST-1) mutant analysis reveals that t cell activation is required for biological effects in the rabbit including the cytokine storm.Semantic proximity Read ↗

Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.Semantic proximity Read ↗

Crystal structure of a biologically inactive mutant of toxic shock syndrome toxin-1 at 2.5 A resolution.Semantic proximity Read ↗

Structures of five mutants of toxic shock syndrome toxin-1 with reduced biological activity.Semantic proximity Read ↗

A toxic shock syndrome toxin 1 mutant that defines a functional site critical for T-cell activation.Semantic proximity Read ↗

Vaccination with nontoxic mutant toxic shock syndrome toxin 1 protects against Staphylococcus aureus infection.Semantic proximity Read ↗

Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.Semantic proximity Read ↗

A Novel High-Potency Tetanus Vaccine.Semantic proximity Read ↗

Microbiology of toxic shock syndrome: overview.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.